The (impressive) safety profile of the RSV vaccine is shown on slides 12-13
vaccine tolerability better than GSK (as expected) efficacy is lower however (10% or so ) Pfizer did maintain efficacy in over 70yo no data on duration yet which might swing in GSK's favor given adjuvenation